The searchable archive below contains a list of Knight ADRC Tuesday Seminar presenters, the date of their presentation, institutional affiliation, and the title of their talk. The archive starts in 2000 with listings displayed in reverse chronological order (most recent first). Note that prior to 2020, some events may be missing or inaccurate due to last minute changes/cancellations.
Total Entries: 1332
| Date | Presenter | Affiliation | Title |
|---|---|---|---|
| August 2, 2016 | Hong Chen, PhD | WashU | Noninvasive and Targeted Drug Delivery to the Brain Using Focused Ultrasound |
| July 26, 2016 | No Seminar | AAIC | |
| July 19, 2016 | No Seminar | AAIC Poster Session | |
| July 12, 2016 | Catherine M. Roe, Ganesh M. Babulal, & Sarah H. Stout | WashU | |
| July 5, 2016 | Tirth Patel | WashU | Investigating Role of Extracellular Tau Species in Pathogenesis and Progression of AD and Other Tauopathies |
| June 28, 2016 | Thomas Esparza | WashU | Purification and Quantitative Characterization of Amyloid-Beta Oligomers from AD Brain Lysates |
| June 21, 2016 | John C. Morris, MD | WashU | State of the Knight ADRC Lecture |
| June 14, 2016 | Sharlee Climer, PhD | WashU | Combinatorial GWAS for Alzheimer’s Disease |
| June 7, 2016 | Babak Razani, MD, PhD | WashU | Is Atherosclerosis the Alzheimer’s Disease of Blood Vessels? How the Cardiovascular and Neurodegenerative Fields Can Learn from One Another |
| May 31, 2016 | Nigel Cairns, PhD | WashU | Aging, Concussion and Will Smith: Update on the Neuropathology of Tauopathies |
| May 24, 2016 | Kevin Black, MD | WashU | Treatment of Parkinson’s Disease Psychiatric Manifestations: Novel Approaches and Clinical Trial Design Considerations |
| May 17, 2016 | David Soleimani-Meigooni | WashU | Creutzfeldt-Jakob Disease |
| May 10, 2016 | Tom J. Brett, PhD | WashU | TBA |
| May 3, 2016 | No Seminar | Hope Center Retreat | |
| April 26, 2016 | Berislav V. Zlokovic, MD, PhD | University of Southern California | TBA |
| April 19, 2016 | No Seminar | AAN Meeting | |
| April 12, 2016 | David K. Johnson, PhD | University of Kansas | A Predictive Prognostic Model for the Longitudinal Transition into Alzheimer’s Disease; A Test of Biomarker Contribution to Disease State |
| April 5, 2016 | Chengjie Xiong, Elzabeth Grant, Scot Fague, Sade Agboola | WashU | Data Collection and Ensuring Reproducible Results |
| March 29, 2016 | Tirth Patel | WashU | TBA |
| March 22, 2016 | Chengjie Xiong, Elzabeth Grant, Scot Fague, Sade Agboola | WashU | Data Collection and Ensuring Reproducible Results |
| March 15, 2016 | Rebecca Dresser, JD | WashU | How Biomarkers for Alzheimer’s Disease Could Affect End-of-Life Choices |
| March 8, 2016 | Sam Nemanich | WashU | Predictors of Gait Speeds and the Relationship of Gait Speeds to Falls in Men and Women with Parkinson Disease |
| March 1, 2016 | Kathleen Schoch, PhD | WashU | Antisense Oligonucleotide-mediated MAPT Splicing Reveals a Toxic Tau Isoform in Mouse Models of Tauopathy |
| February 23, 2016 | Liang Wang, PhD | WashU | Tau PET Imaging: Initial Experience at Staging of AD and Revealing the Interaction of Amyloid and Tau Pathology |
| February 16, 2016 | Richard J. Perrin, MD, PhD | WashU | Beyond Abeta and PIB for Preclinical AD: Novel Fluid Markers; Novel Insights |